Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.”
GM’s stock slips as car giant updates guidance amid tariff impact
GM said its initial full-year 2025 guidance “does not contemplate the potential impact of tariffs.”
